Results 241 to 250 of about 36,524 (294)

Catheterization complications of intra-arterial chemotherapy for retinoblastoma. [PDF]

open access: yesJ Neurointerv Surg
Schreiber C   +6 more
europepmc   +1 more source

Nanomaterial-based ophthalmic drug delivery

Advanced Drug Delivery Reviews, 2023
The low bioavailability and side effects of conventional drugs for eye disease necessitate the development of efficient drug delivery systems. Accompanying the developments of nanofabrication techniques, nanomaterials have been recognized as promising tools to overcome these challenges due to their flexible and programmable properties.
Guocheng Xie   +3 more
openaire   +2 more sources

Cyclodextrins in ophthalmic drug delivery

Advanced Drug Delivery Reviews, 1999
Most ocular diseases are treated by topical drug application in the form of aqueous eye drop solutions. Recent studies have shown that cyclodextrins are useful additives in ophthalmic formulations for increasing the aqueous solubility, aqueous stability and bioavailability of ophthalmic drugs, and to decrease drug irritation.
, Loftssona, , Järvinen
openaire   +2 more sources

Ophthalmic drug delivery systems

Drug Development Research, 1984
AbstractNew ophthalmic drug delivery systems are curently receiving increased attention, in part because of the expected emergence of new drugs with short biological half‐lives whose usefulness may depend on a more continuous drug supply than eyedrops can provide, but also because of the potential of some delivery systems to reduce the side effects of ...
openaire   +2 more sources

Ophthalmic Drug Delivery: New Dimensions

International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), 2023
The objective of this review is to compile updated scientific information on the conventional and novel approaches to the ocular delivery of medication. Owing to the special features and requirements of a specific site delivery system, there is a need for the refinement of novel drug delivery systems.
RAJAT BUDHORI   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy